跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
健择 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Gemcitabine Hydrochloride for Injection
Approved
化学药品
Gemcitabine Hydrochloride for Injection
LILLY FRANCE
🇨🇳 National Medical Products Administration
Approval Date
Dec 28, 2022
Approval ID
1xpZtrN2y4O
Company
LILLY FRANCE
Type
化学药品
Approval Details
Approval Id
1xpZtrN2y4O
Approval Number
国药准字HJ20160224
Generic Name
注射用盐酸吉西他滨
Generic Name En
Gemcitabine Hydrochloride for Injection
Trade Name
健择
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.2g(按C₉H₁₁F₂N₃O₄计)
Reg Date
2022-12-28
Expired Date
2027-12-27
Company Name
LILLY FRANCE
Company Detail Path
/organization/lilly-france
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 28, 2022
Approval ID
1xpZtrN2y4O
Type
化学药品
Back to NMPA Approvals